Table 1 Participant demographics
From: Impact of vaccination and variants of concern on long COVID clinical phenotypes
Whole cohort (n = 417) | WT (n = 268) | VOC (n = 149) | P value | |
|---|---|---|---|---|
Age (years) | 45 (35–55) | 43 (36–54) | 47 (34–57) | 0.2 |
Sex (F) | 307 (73) | 196 (73) | 109 (73) | 0.9 |
Ethnicity (Caucasian) | 352 (84) | 222 (84) | 129 (87) | 0.31 |
BMI (kg/m2) | 28 (24–32) | 28 (24 – 32) | 28 (24 – 33) | 0.6 |
HCW | 215 (51) | 163 (61) | 51 (35) | < 0.001 |
Smoking | 19 (4) | 12 (4.5) | 7 (4.7) | 0.9 |
Alcohol | 125 (30) | 80 (30) | 45 (30) | 0.9 |
Comorbidity (Any) | 243 (56) | 152 (59) | 89 (60) | 0.9 |
Hypertension | 74 (18) | 45 (18) | 28 (19) | 0.8 |
Diabetes | 23 (5) | 14 (5.5) | 9 (6.1) | 0.9 |
Respiratory | 78 (19) | 45 (18) | 32 (22) | 0.4 |
-Asthma | 62 (15) | 36 (13) | 25 (17) | 0.43 |
Cardiac | 21 (5) | 13 (5.1) | 8 (5.4) | 0.9 |
Immunosuppression | 5 (1) | 2 (0.8) | 3 (2) | 0.5 |
Psychiatric | 10 (2) | 8 (3) | 2 (1) | 0.47 |
Vaccinated at time of infection | 15 (3) | 0 (0) | 15 (11) | < 0.001 |
Vaccinated at time of review | 157 (37) | 60 (25) | 97 (75) | < 0.001 |
Time from symptom onset (weeks) | 22 (13–35) | 24 (16–38) | 18 (10–31) | < 0.001 |
Mild initial disease severity | 330 (79) | 217 (83) | 112 (75) | 0.07 |
Hospitalised at acute infection | 129 (31) | 75 (28) | 54 (36) | 0.11 |